Wall Street Analysts Think LifeStance Health (LFST) Could Surge 26.68%: Read This Before Placing a Bet

Core Viewpoint - LifeStance Health Group (LFST) shows potential for further upside, with a mean price target of $7.93 indicating a 26.7$6.26 [1] Price Target Analysis - The mean estimate consists of seven short-term price targets with a standard deviation of $1.43, indicating variability among analysts [2] - The lowest estimate is$6, suggesting a 4.2% decline, while the highest estimate is $10, indicating a potential surge of 59.7% [2] - A low standard deviation signifies a high degree of agreement among analysts regarding the stock's price movement [7] Earnings Estimates - Analysts have shown increasing optimism about LFST's earnings prospects, with a strong consensus in revising EPS estimates higher [9] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 3.9%, with two estimates moving higher and no negative revisions [10] - LFST holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [11]